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Background/aim: To evaluate the influence of caffeic acid phenethyl ester (CAPE) on cigarette smoke (CS)-induced cell damage,
oxidative stress, and inflammation in human alveolar epithelial cells.
Materials and methods: A549 alveolar epithelial cells were divided into control, CS exposure, CAPE, and CS+CAPE treatment groups.
Undiluted CS-exposed medium (100%) and three dilutions (50%, 25%, and 10%) of CS-exposed media were applied to cultured A549
cells, which were analyzed after 3 h of incubation. Viability was measured by MTT assay, the gene expressions were evaluated by realtime PCR, and spectrophotometric techniques were used for biochemical assessments.
Results: While CS exposure markedly reduced cellular viability by 32% after 3 h of incubation, 2.5 µM CAPE treatments prevented CSinduced cell death by 40% in the cells. CS exposure triggered lipid peroxidation and depleted antioxidant capacity through inhibiting
catalase activity and depleting glutathione levels. Moreover, CS increased nitric oxide production via upregulation of iNOS expression.
CAPE treatment significantly restored antioxidant capacity and prevented lipid peroxidation. Cigarette smoke exposure induced
inflammation by significantly upregulating TNF-α, IL-1β, and COX-2 mRNA expressions (3-, 2- and 25-fold, respectively). CAPE
treatment of A549 cells significantly reversed the inflammation.
Conclusion: CAPE may potentially represent a new therapeutic option in the prevention of CS-induced lung damages.
Key words: Caffeic acid phenethyl ester, CAPE, inflammation, oxidative stress, cigarette smoke, A549

1. Introduction
Epithelial cells lining the respiratory tract are vulnerable
to excessive proinflammatory response due to direct
exposure to environmental factors such as cigarette smoke
(CS). CS contains more than 4000 harmful chemical
compounds per puff, of which 200 are highly toxic (1).
Many of these chemicals induce an oxidative burden and
lead to inflammatory reactions that could cause cellular
damage in the lungs (2,3). Inhalation of CS resulted in
lung damage by generation of oxidative stress, production
of cytokines, chemokines, and other factors (4). Therefore,
CS is significant as an etiologic factor in the progression
of chronic degenerative lung disorders, such as chronic
obstructive pulmonary disease (COPD) (2,5).
Caffeic acid phenethyl ester (CAPE) is derived from
different plants and is a bioactive constituent found in
bee propolis that may have pharmacological applications.
Recently, a wide range of pharmacological properties
were demonstrated for this substance, including
* Correspondence: suaterdogan@trakya.edu.tr
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antiinflammatory, antioxidant, antiproliferative, and
immunomodulatory activities (6–8). The prominent
protective property of CAPE makes it a potential
therapeutic compound against damage to the kidneys,
brain, lungs, and other tissues or organs. CAPE is a specific
and potent inhibitor of nuclear factor-κB (NF-κB) signaling
(9) and a potent inhibitor of leukotriene biosynthesis;
therefore, CAPE may have a potential therapeutic effect on
inflammatory diseases (10). However, the effects of CAPE
on CS-induced inflammation and oxidative events in the
alveolar epithelium have not been extensively studied yet.
In this study, we explored whether CAPE can prevent
CS-triggered proinflammatory cytokine release and
oxidative stress in human-derived alveolar epithelial cell
lines.
2. Materials and methods
In the present study, A549 cells were used to observe lung
alveolar epithelial cell responses. CS was used to mimic
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inhaled tobacco smoke and the effects of CAPE on CSinduced oxidative stress and inflammatory reactions on
A549 cells were analyzed. Effects of CAPE and CS on cell
proliferation and viability were assessed by MTT assay and
trypan blue exclusion test. All reagents were of analytical
grade and obtained from Sigma Chemical Co. (USA)
unless otherwise stated.
2.1. Cell culture
The human adenocarcinoma epithelial cells (A549)
were maintained in Dulbecco’s modified Eagle medium
(DMEM) complemented with 10% FBS, 100 IU/mL
penicillin, and 100 µg/mL streptomycin. The cells were
incubated at 37 °C in a humidified atmosphere containing
5% CO2 (Heraeus, Heracell 150, Germany). Exponentially
growing A549 cells were used for all assays.
A549 cells were kindly provided by Dr J Mazella
(CNRS, France) and cultured overnight at a density of 10 ×
104/well or 4 × 104/well in sterile 12-well or 24-well plates,
respectively (Costar, Corning Inc., USA). To quantify the
concentration of exogenously applied CS in the culture
medium over time, the medium was removed, and a fresh
medium containing 10%–100% CS was added. The cells
were incubated for 3 h.
CS was prepared according to the reported method
with minor modifications (11). Commercial unfiltered
cigarettes (Marlboro, Philips Morris, Inc., USA; 12 mg of
tar and 0.9 mg of nicotine per cigarette) were smoked and
drawn continuously by the apparatus. By application of a
vacuum, mainstream smoke was drawn through a vessel
containing 20 mL of DMEM that was prewarmed to 37 °C.
Each cigarette was smoked for 5 min, and one cigarette was
used per 20 mL of DMEM to generate a CS solution. Its
pH was adjusted to 7.4 and it was filtered through a 0.22µm pore filter and used within 30 min after preparation.
The cells were exposed to CS-containing medium for 3 h.
Final concentration of this solution is expressed as percent
values, which was calculated with the following equation:
(mL CS solution/total mL) × 100.
2.2. MTT and trypan blue exclusion assays
To test the cytoprotective effects, the cells were pretreated
with CAPE 1 h before CS exposure, and then cells were
stressed with CS for 3 h. Cell viability was measured by both
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) (Fluka, USA) assay and trypan blue dye
exclusion. In some cases, the remaining adherent cells
were photographed using a CKX41 model Olympus phase
contrast microscope (Japan). CAPE concentrations (2.5
µM CAPE and 100% CS) used for the treatments were
chosen to obtain maximal effects. Concentrations of CAPE
and CS were determined by dose-response studies.
2.3. Homogenate preparation
After CS exposure, cells were homogenized in ice-cold
homogenization buffer (10 mM Tris, 1 mM EDTA, 25

mM MgCl2, 0.1 mM dithiothreitol, 0.25 M sucrose, pH
7.4) containing a complete protease inhibitor cocktail.
After centrifugation at 4 °C and 15,000 rpm for 10 min,
the soluble part was reserved. Protein concentrations were
analyzed using bovine serum albumin as a standard.
2.4. Determination of nitrite levels
The concentration of NO in culture media was determined
as nitrite, using the Griess reaction as described previously
(12).
2.5. Determination of glutathione levels
Nonenzymatic antioxidant glutathione (GSH) content of
A549 cell homogenates was determined according to the
method of Sedlak and Lindsay (13).
2.6. Assessment of lipid peroxidation
The lipid peroxidation level was evaluated by measuring the
concentrations of cellular homogenate malondialdehyde
(MDA) (14).
2.7. Measurement of catalase activity
Catalase activity in the cell homogenate was determined
according to the method of Luck (15), and the activity was
presented as unit k/mg protein, where k is the rate constant
of a first-order reaction.
2.8. RNA isolation and real-time QRT-PCR analyses
A549 cells in culture are known to express proinflammatory
cytokines such as TNF-α and IL-1β in response to stimuli
that trigger inflammatory responses. To examine whether
CAPE effectively inhibits oxidative stress-induced
inflammation in our experimental conditions, A549
cells were exposed to 100% CS for 3 h. Total RNA from
A549 cells was isolated using TRIzol reagent. RNA was
reverse-transcribed using a transcriptase kit (Fermentas,
Germany). Real-time PCR was carried out in a QPCR
system (Stratagene Mx 3005P, Lenexa, USA). cDNA was
used as a template for amplification using SYBR Green PCR
amplification reagent and gene-specific primers. Primer sets
used were from Thermo Electron Corporation (Germany):
TNF-α
forward:
CAGAGGGAAGAGTTCCCCAG,
reverse: CCTTGGTCTGGTAGGAGACG; IL-1β forward:
5’-GCAAGCGCTTCAGGCAGGCGGCG-3’,
reverse:
5’-GGTCAT TCTCCTGGAAGGTCTGTGGGC-3’;
iNOS
forward:
GGCCTCGCTCTGGAAAGAA,
reverse: TCCATGCAGACAACCTT; COX-2 forward:
5’-TGAAACCCACTCCAAACACACAG-3’,
reverse:
5’-TCATCAGGCACAGGAGGAAG-3’. The amount of
RNA was normalized to β-actin amplification in a separate
reaction forward: CATCGTCACCAACTGGGACGAC,
reverse: CGTGGCCATCTCTTGCTCGAAG.
2.9. Statistical analysis
The results are presented as the mean ± standard error of
at least three experiments. The level of significance was
set at P < 0.05. Data obtained from various groups were
statistically evaluated using one-way ANOVA followed by
post hoc Duncan tests (SPSS 9.0 for Windows).
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3. Results
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3.1. Effect of CAPE treatment (incubation) on CSexposed cellular viability
Concentration response course demonstrated that a CAPE
dose of more than 2.5 µM had cytotoxic effects (Figure 1A).
For this reason, 2.5 µM CAPE was used as a cell-protective
concentration for further experiments. Viability of A549
cells decreased steadily in a concentration-dependent
manner over the range of 50% to 100% following 3 h of
CS exposure (Figures 1B and 1C). The data showed that
100% CS killed 32% of cells at the end of 3 h incubation,
and CAPE prevented 40% of the cell death caused by
CS (Figure 1C). Cells were evaluated with a microscope
for morphologic changes. It was noted that many cells
detached from the flask following CS exposure (Figure
2). Conversely, the majority of cells recovered after CAPE
treatment (Figure 2, CS+CAPE).
There was a significant induction in nitrite levels in CSexposed cells when compared to the control (Figure 3). CS
similarly increased iNOS mRNA expression by 2.2-fold
(Figure 4). A significant reduction in both NO production

and iNOS mRNA expression was observed in cells treated
with 2.5 µM CAPE (Figures 3 and 4).
To determine the effect of CS exposure on oxidant and
antioxidant homeostasis, we also measured reduced GSH
levels in cells with or without CS. There was a significant
(27%) reduction in GSH levels in CS-exposed cells when
compared to the control. On the other hand, CAPE
completely recovered the loss of GSH caused by exposure
(Figure 3).
Lipid peroxidation levels (MDA) were measured in
A549 cells as a marker of oxidative stress (Figure 3). MDA
levels were compared in the CS+CAPE-treated group
and the control group (nonexposed group). Significantly
increased MDA levels were observed in the CS-exposed
group (P < 0.001) in comparison to the control group.
However, CAPE significantly (P < 0.001) reduced lipid
peroxidation induced by CS.
Catalase is an important antioxidant enzyme actively
involved in quenching harmful radicals contained in CS.
The cells exposed to CS had significantly low levels of
catalase activity (Figure 3), while 2.5 µM CAPE treatment
for 3 h increased catalase activity by 50%.
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Figure 1. Effects of CAPE and cigarette smoke (CS) on A549 cell viability. Cells were seeded 24 h before the assay in 24-well
plates at a density of 4 × 104 cells per well in complete medium. One hour before CS exposure, cells were pretreated with CAPE at
indicated concentrations for 3 h, and cell viability was determined by MTT assay (A). The cells were exposed to 10%, 25%, 50%, or
100% CS-containing medium, respectively, for 3 h (B), and then the viability was determined using MTT test. The effect of CAPE
(2.5 µM) on 100% CS exposure was estimated by trypan blue exclusion test after 3 h incubation (C). Data represent the means of
three independent experiments and were compared using one-way ANOVA test. *: P < 0.05, **: P < 0.01 vs. control (0); ¥: P < 0.01,
¥¥
: P < 0.05 vs. control (0). C: Control, CS: cigarette smoke, CS+CAPE: cigarette smoke + caffeic acid phenethyl ester.
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Figure 2. CS resulted in morphologic changes and viability loss of A549 cells. After treatment with 100% CS or 2.5 µM
CAPE for 3 h, cells were observed under inverted microscope. Closely adherent cells were seen in the control group (C).
The cells showed lowered numbers after exposure to CS (SC). It was noted that some cells detached from the flask (CS).
However, a majority of the cells were recovered after CAPE treatment (CS+CAPE). Phase contrast microscopy, original
magnification, 40×. C: Control, CS: cigarette smoke, CS+CAPE: cigarette smoke + caffeic acid phenethyl ester.

3.2. Effect of CAPE on COX-2 mRNA expressions in
A549 cells exposed to CS
As COX-2-dependent prostanoids play a central role in
inflammation, the role of COX-2 mRNA expression was
investigated. CS treatment upregulated COX-2 mRNA by
25-fold in A549 cells (Figure 4).
CS exposure significantly induced TNF-α (3 fold) and
IL-1β (2 fold) mRNA expression compared to the control
cells. Additionally, CS-induced cytokine expression was
reversed by 2.5 µM CAPE treatments (P < 0.001) (Figure 4).
4. Discussion
The aim of this study was to evaluate the antiinflammatory
and antioxidant properties of CAPE treatment on CSinduced airway epithelial injury. We demonstrated that
CAPE could protect alveolar epithelial cells against

oxidative and inflammatory stress-induced damage of CS
for the first time in the literature (16).
We hypothesized that CS caused cytotoxic effects
because of the presence of very reactive compounds present
in CS (2,17,18) or because of the production of cytoplasmic
reactive oxygen/nitrogen species (17). Undeniably, studies
have demonstrated that the cytotoxic capacity of CS is
due to a number of chemical components (17–19). These
results suggest that CAPE is an effective exogenous cell
protective mediator against oxidative injury.
Disturbance of prooxidant and antioxidant balance
has been reported to result in lung tissue injury in tobacco
smokers (2,7,19). Excessively produced NO derived from
inducible NOS (iNOS) has been demonstrated to play a
key role in development of inflammation and oxidative
stress in the lungs (20). In our study, induction of iNOS
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Figure 3. CAPE pretreatment enhanced antioxidant system and prevented lipid peroxidation induced by CS. Nitric oxide (NO)
concentration was measured in culture medium as nitrate 3 h after incubation with or without 100% CS and 2.5 µM CAPE (A).
Glutathione (B) and lipid peroxidation (MDA) (C) levels and catalase activity (D) were measured using cultured cell homogenates.
CAPE was administrated 1 h before CS-exposed medium addition. Data represent one of three independent experiments with
similar results. *: P < 0.01 vs. C (control); **P < 0.01 vs. CS (cigarette smoke).

expression by CS exposure and subsequent production
of NO was significantly inhibited by CAPE pretreatment.
The decrease in iNOS activity by CAPE administration
may contribute to the high risk of lung disease in cigarette
smokers.
In addition, GSH is a crucial intracellular antioxidant
and provides an important defense in the lungs. Cigarette
smoking has been proven to induce oxidative stress
and reduce GSH homeostasis (2,7). We have shown
that exposure of A549 cells to CS resulted in significant
depletion of GSH concentration. As suggested previously
by Rahman et al., CS-mediated reduction of GSH content
might be due to the formation of GSH conjugates with
the electrophilic β-carbonyl compounds in CS (21).
Furthermore, our observation is consistent with earlier
findings of CS’s ability to induce oxidative stress by
generating reactive oxygen species and decreasing cellular
GSH levels (21). We have shown that CAPE dramatically
blocked GSH depletion in cells exposed to CS. These
effects could be dramatically inhibited by CAPE. This
suggests that CAPE can provide a promising approach
for the treatment or protection of CS-related pulmonary
diseases (7,19).
It has been reported that CS increased the degree of lipid
peroxidation via oxidative stress in human lung epithelial
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cells and fibroblasts (22,23). We have demonstrated
here that CS exposure caused lipid peroxidation in lung
alveolar epithelial cells as measured by determining
MDA concentrations. Administration of CAPE to CSexposed cells significantly prevented lipid peroxidation,
indicating that CAPE may protect the lungs from CS
stress. This result is in agreement with a previous study
highlighting the effect of CS exposure on the prevention
of histopathological changes in rabbit airway epithelium
(24).
In the present study, CS exposure significantly decreased
activity of catalase, an antioxidant enzyme associated with
H2O2 hydrolyses. Mak et al. (25) showed that erythrocyte
catalase activity increased in patients with COPD, which
is different from our findings. However, Tavilani et al. (26)
and some others demonstrated that antioxidant enzyme
might be downregulated during severe or chronic oxidant
exposure (27). CAPE incubation significantly restored
catalase activity in this study. The result suggests that
CAPE would prevent CS-induced oxidative damage in
lungs by supporting antioxidant defense system.
Since there is an active interplay between oxidative stress
and inflammation, we also evaluated the antiinflammatory
activity of CAPE in CS-exposed A549 cells. Previous studies
demonstrated that persistent CS exposure induced airway
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Figure 4. Real time RT-PCR analyses of iNOS, COX-2, TNF-α, and IL-1β expressions in A549 cells. The mRNA levels of iNOS (A),
COX-2 (B), TNF-α (C), and IL-1β (D) were determined using QRT-PCR in order to evaluate possible protective effects of 2.5 µM
CAPE against 100% CS exposure. Results were expressed as a relative increase of mRNA expression compared with control cells.
Experiments shown are representative of three separate analyses with similar results. *: P < 0.001 vs. control (C), **: P < 0.001 vs. CS.
C: Control, CS: cigarette smoke, CS+CAPE: cigarette smoke + caffeic acid phenethyl ester.

inflammatory reactions, with elevated proinflammatory
cytokine levels, which are generally regulated by
proinflammatory gene transcription factors (7,28). TNF-α
and IL-1β secretion was shown to be induced by a wide
variety of agents including stress, CS, cytokines, and free
radicals (29). In the present study, CAPE application
suppressed TNF-α and IL-1β mRNA expressions that had
been induced by CS. The proinflammatory cytokine TNF-α
is the key proinflammatory mediator that initiates a rapid
increase in mitochondrial reactive oxygen species and
triggers necrosis and apoptosis (30). During inflammatory
stimulation, translocation of NF-κB from the cytosol into
the nuclei of cells induces the expression of a large number
of genes such as TNF-α, IL-1β, acute phase proteins, and
enzymes such as iNOS (7). CS promotes the induction of
COX-2 and contributes to the proinflammatory effects
of PGE2 in the airways of COPD patients (31). CAPE
may exert antiinflammatory properties through the
suppression of COX-2 expression. These results propose
that inflammation induced by CS could be suppressed

by CAPE through inhibition of the production of some
inflammatory mediators.
Our data have demonstrated that CAPE has antioxidative
and antiinflammatory properties associated with inhibition
of inflammatory cytokine production, as well as iNOS and
COX expressions in an alveolar cell culture model. Therefore,
CAPE might play a protective role in degenerative lung
diseases associated with cigarette smoking. It should be
noted that this cell line may not accurately represent the in
vivo situation, as the phenotype of immortalized cells often
differs from that of the normal tissue. For instance, A549
cells are not as sensitive to cigarette smoke exposure as
primary cultures (32). Thus, further in vivo studies should
be performed to determine whether CAPE could provide a
valuable therapeutic potential.
Acknowledgment
This study was supported by the Mustafa Kemal University
(the former address of the corresponding author) Scientific
Research Projects Committee (Project No. 1004Y0115).

539

BARLAS and ERDOĞAN / Turk J Med Sci
References
1.

Brunnemann KD, Hoffmann D. Analytical studies on tobaccospecific N-nitrosamines in tobacco and tobacco smoke. Crit
Rev Toxicol 1991; 21: 235–240.

15.

Luck H. Catalase. In: Bergmeyer HU, editor. Methods of
Enzymatic Analysis. Weinheim, Germany: Verlag Chemie;
1965.

2.

Kode A, Yang SR, Rahman I. Differential effects of cigarette
smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respir Res 2006; 7:
132–151.

16.

3.

Pekmez H, Ogeturk M, Ozyurt H, Sonmez MF, Colakoglu N,
Kus I. Ameliorative effect of caffeic acid phenethyl ester on histopathological and biochemical changes induced by cigarette
smoke in rat kidney. Toxicol Ind Health 2010; 26: 175–182.

Sirmali M, Solak O, Tezel C, Sirmali R, Ginis Z, Atik D,
Agackıran Y, Koylu H, Delibas N. Comparative analysis of the
protective effects of caffeic acid phenethyl ester (CAPE) on
pulmonary contusion lung oxidative stress and serum copper
and zinc levels in experimental rat model. Biol Trace Elem Res
2013; 151: 50–58.

17.

4.

Van der Vaart H, Postma D, Timens W, Ten H. Acute effects of
cigarette smoke on inflammation and oxidative stress: a review.
Thorax 2004; 59: 713–721.

Pouli AE, Hatzinikolaou DG, Piperi C, Stavridou A, Psallidopoulos MC, Stavrides JC. The cytotoxic effect of volatile organic compounds of the gas phase of cigarette smoke on lung
epithelial cells. Free Radic Biol Med 2003; 34: 345–355.

18.

5.

Saetta M. Airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: S17–20.

Pryor WA, Stone K. Oxidants in cigarette smoke. Radicals,
hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann NY
Acad Sci 1993; 686: 12–28.

19.

6.

Celik S, Erdogan S. Caffeic acid phenethyl ester (CAPE) protects brain against oxidative stress and inflammation induced
by diabetes in rats. Mol Cell Biochem 2008; 312: 39–46.

Rahman I, MacNee W. Lung glutathione and oxidative stress:
implications in cigarette smoke-induced airway disease. Am J
Physiol 1999; 277: L1067–1088.

20.

Thatcher TH, Hsiao HM, Pinner E, Laudon M, Pollock SJ, Sime
PJ, Phipps RP. Neu-164 and Neu-107, two novel antioxidant
and anti-myeloperoxidase compounds, inhibit acute cigarette
smoke-induced lung inflammation. Am J Physiol Lung Cell
Mol Physiol 2013; 15: L165–174.

21.

Rahman I, Li XY, Donaldson K, Harrison DJ, MacNee W. Glutathione homeostasis in alveolar epithelial cells in vitro and
lung in vivo under oxidative stress. Am J Physiol 1995; 269:
L285–292.

22.

Baglole CJ, Bushinsky SM, Garcia TM, Kode A, Rahman I,
Sime PJ, Phipps RP. Differential induction of apoptosis by
cigarette smoke extract in primary human lung fibroblast
strains: implications for emphysema. Am J Physiol Lung Cell
Mol Physiol 2006; 291: L19–29.

23.

Itoh M, Tsuji T, Nakamura H, Yamaguchi K, Fuchikami JI,
Takahashi M, Morozumi Y, Aoshiba K. Systemic effects of
acute cigarette smoke exposure in mice. Inhal Toxicol 2014; 16:
1–10.

24.

Sezer M, Sahin O, Solak O, Fidan F, Kara Z, Unlu M. Effects of
caffeic acid phenethyl ester on the histopathological changes
in the lungs of cigarette smoke-exposed rabbits. Basic Clin
Pharmacol Toxicol 2007; 101: 187–191.

7.

Chen L, Sun BB, Wang T, Wang X, Li JQ, Wang HX, Zhang SF,
Liu DS, Liu L, Xu D et al. Cigarette smoke enhances β-defensin
2 expression in rat airways via nuclear factor-κB activation. Eur
Respir J 2010; 36: 638–645.

8.

Lin YT, Hsu JY, Chen CJ, Chu JJ, Fu LS. Caffeic acid phenethyl
ester suppresses eotaxin secretion and nuclear p-STAT6 in human lung fibroblast cells. J Microbiol Immunol Infect 2011; 44:
435–441.

9.

Lee Y, Shin DH, Kim JH, Hong S, Choi D, Kim YJ, Kwak MK,
Jung Y. Caffeic acid phenethyl ester-mediated Nrf2 activation
and IκB kinase inhibition are involved in NFκB inhibitory effect: structural analysis for NFκB inhibition. Eur J Pharmacol
2010; 643: 21–28.

10.

Boudreau LH, Maillet J, LeBlan LM., Jean-François J, Touaibia
M, Flamand N, Surette ME. Caffeic acid phenethyl ester and its
amide analogue are potent inhibitors of leukotriene biosynthesis in human polymorphonuclear leukocytes. Plos One 2012; 7:
e31833.

11.

Su Y, Han W, Giraldo C, De Li Y, Block ER. Effect of cigarette
smoke extract on nitric oxide synthase in pulmonary artery
endothelial cells. Am J Respir Cell Mol Biol 1998; 19: 819–825.

12.

Cortas NK, Wakid NW. Determination of inorganic nitrate
in serum and urine by a kinetic cadmium-reduction method.
Clin Chem 1990; 36: 1440–1443.

13.

Sedlak J, Lindsay RH. Estimation of total, protein-bound, and
nonprotein sulfhydryl groups in tissue with Ellman’s reagent.
Anal Biochem 1968; 25: 192–205.

14.

Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation
in maternal and cord blood and protective mechanism against
activated-oxygen toxicity in the blood. Am J Obstet Gynecol
1979; 135: 372–376.

540

25.		 Mak JC, Ho SP, Yu WC, Choo KL, Chu CM, Yew WW, Lam
WK, Chan-Yeung M. Polymorphisms and functional activity
in superoxide dismutase and catalase genes in smokers with
COPD. Eur Respir J 2007; 30: 684–690.
26.

Tavilani H, Nadi E, Karimi J, Goodarzi MT. Oxidative stress in
COPD patients, smokers, and non-smokers. Respir Care 2012;
57: 2090–2094.

27.

Gilks CB, Price K, Wright JL, Churg A. Antioxidant gene
expression in rat lung after exposure to cigarette smoke. Am J
Pathol 1998; 152: 269–278.

BARLAS and ERDOĞAN / Turk J Med Sci
28.

Liu X, Togo S, Al-Mugotir M, Kim H, Fang Q, Kobayashi T,
Wang X, Mao L, Bitterman P, Rennard S. NF-κB mediates the
survival of human bronchial epithelial cells exposed to cigarette smoke extract. Respir Res 2008; 9: 66–76.

29.

Braber S, Henricks PAJ, Nijkamp FP, Kraneveld AD, Folkerts
G. Inflammatory changes in the airways of mice caused by cigarette smoke exposure are only partially reversed after smoking
cessation. Respir Res 2010; 11: 99–109.

30.

Pierce RH, Campbell JS, Stephenson AB, Franklin CC, Chaisson M, Poot M, Kavanagh TJ, Rabinovitch PS, Fausto N. Disruption of redox homeostasis in tumor necrosis factor-induced
apoptosis in a murine hepatocyte cell line. Am J Patho 2000;
157: 221–236.

31.

Profita M, Sala A, Bonanno A, Riccobono L, Ferraro M, La
Grutta S, Albano GD, Montalbano AM, Gjomarkaj M. Chronic
obstructive pulmonary disease and neutrophil infiltration: role
of cigarette smoke and cyclooxygenase products. Am J Physiol
Lung Cell Mol Physiol 2010; 298: L261–269.

32.

Newland N, Richter A. Agents associated with lung inflammation induce similar responses in NCI-H292 lung epithelial
cells. Tox In Vitro 2008; 22: 1782–1788.

541

